ADITI SWAMY, POSTGRAD ASSOCIATE
Aditi joined the lab in March 2024 after graduating with an M.Sc. in Molecular Medicine. She is currently investigating CDK11 as a target for cancer therapy.
Debanjan Bhattacharjee, POSTDOC
Debanjan joined the lab in May 2022 as a postdoc to study the on-target and off-target effects of cancer drugs.
Greg Gauthier-Coles, POSTDOC
Greg joined the lab in December 2022 as a postdoc to develop new approaches to characterize the mechanisms of anti-cancer drugs.
Klaske Schukken, postdoc
Klaske received her PhD from the University of Groningen. Klaske is conducting CRISPR screens to identify therapeutic vulnerabilities caused by aneuploidy.
Jason Sheltzer, PI
Jason Sheltzer received a Ph.D. in Biology from the Massachusetts Institute of Technology. His research interests include aneuploidy, genomic instability, mitotic kinases, molecular pharmacology, and genome engineering.
SANAT MISHRA, biostatistician
Sanat is a computational biologist who joined the lab in May 2024. Fueled by coffee, Sanat manages all areas of computational biology within the lab.
Sarah thompson, staff scientist
Sarah received a Ph.D. in Biochemistry from Dartmouth College. Sarah is using CRISPR-based chromosome engineering tools to study specific chromosomal gains in tumorigenesis.
JOAN SMITH, SOFTWARE ENGINEER
Joan is a principal engineer at Google, working on AI infrastructure. In her work with the Sheltzer Lab, Joan builds tools to analyze cancer survival data and identify biomarkers associated with cancer patient prognosis and drug response.
Kate Long, POSTGRADUATE RESEARCHER
Kate is characterizing a novel compound capable of eliminating drug-resistant cancers.
Yi Bei, postdoc
Yi joined the lab in September, 2024 after completing his PhD at Humboldt University in Berlin. Yi is working to discover how aneuploidy affects cancer progression and epigenetic reprogramming.
jess keane, POSTGRAD ASSOCIATE
Jess joined the lab in July 2024 after graduating with a B.S. in Biochemistry from the University of Washington. Jess is currently focusing on investigating aneuploidy-associated target genes for therapeutic inhibition
Mason Lynch, Postgraduate Associate
Mason joined the lab in 2024 completing a bachelor’s degree in Cell and Molecular Biology at Occidental College. Mason is characterizing the effects of losing the Y chromosome in cancer cells.